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Intramedullary Spinal Cord Metastases
and Radiation Therapy: A Case Report
Daniel Ikeda, James S. Harrop MD
Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania

Introduction
Intramedullary spinal cord metastases (ISCM) are a clinically rare, although devastating, complication
of disseminated cancer. These lesions have been reported to originate from many types of solid
tumors, although primary lung carcinoma, particularly small cell, is the most common etiology.
These metastases, which can occur anywhere along the spinal cord, often represent the end-stage of
the disease process with limited survival outcomes.
Patients with ISCM may develop a variety of neurological deficits with treatment goals aimed at
palliation. Different modalities of treatment have been found to preserve or restore ambulation and
neurological function. The options for therapeutic intervention include surgical, chemotherapeutic,
and radiation therapy. We describe a case of ISCM in a patient with disseminated small cell lung
cancer with magnetic resonance imaging that illustrates a complete tumor response to radiation
therapy

Case Report

Figure 1A
Cervical MRI, prior to 30 Gy radiotherapy

In December of 2006, a 63 year-old male presented with extensive stage small cell lung carcinoma.
Upon initial presentation, this patient had a very large, left pulmonary mass, mediastinal lymphadenopathy, multiple hepatic lesions, and several osseous lesions. Due to the extent of his disease,
the patient was referred to medical oncology and treated with chemotherapy. A PET scan on July of
2007 revealed radiographic resolution of his malignancy following his chemotherapy. On October
3rd of 2007, after presenting with dizziness, it was found he had metastasis to his cerebellar vermis.
These metastases were treated with 30 Gy of whole brain radiation therapy and his vertigo significantly improved. A follow-up brain MRI showed a complete response to treatment with no residual
metastases found.
In December of 2007, the patient presented with bilateral shoulder and neck pain. The pain started
in his right shoulder radiating to his mid neck and then to his left shoulder. The pain had been
intermittent, but intense, over the previous few weeks and progressed to right arm numbness. There
was no associated muscle weakness in his upper or lower extremities bilaterally. The patient displayed
some mild right hand intrinsic weakness; deep tendon reflexes were found to be slightly increased
in his lower extremities versus his upper extremities. An open MRI with and without IV contrast
of the cervical spine was performed. A contrast enhancing mass within the cervical spinal cord was
noted and reported as an ependymoma, due to the infrequency of intraparenchymal metastasis. To
get better definition of the lesion, a repeat closed high-resolution MRI of the cervical, thoracic, and
lumbar spine was performed. The cervical contrast enhancing lesion was found to be three separate
intramedullary multifocal with measured total length of 4.5 cm (Figure 1A). There were no other
lesions in the spinal cord. The presence of three distinct lesions in the setting of metastatic disease was
consistent with multiple intraparenchymal metastatic disease rather than a primary intramedullary
neoplasm (ependymoma).
The patient’s disease was in remission and 30 Gy of cervical spine radiation was administered. The
patient reported that his symptoms of pain and numbness resolved completely with the radiation
therapy.
A follow-up MRI demonstrated a complete response and no evidence of the ISCM lesion (Figure 1B).

Discussion
Although rarely reported, ISCM have been found in 0.9% to 2.1% of cancer patients by autopsy,
suggesting that thousands of patients are afflicted yearly1. Primary lung carcinoma is the most common etiology and reported to occur in up to fifty percent of cases of ISCM2. In one retrospective
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Figure 1B
Cervical MRI, post radiotherap

study, small cell lung cancer was the most common primary tumor in patients with ISCM,
accounting for 63% of patients with primary
lung cancer and 30% of all patients studied2.
However, other solid tumors, including breast,
kidney, colorectal, cervical, and ovarian cancers
have also been reported3,4,5.
A variety of neurological disorders characterizes the presenting symptoms of ISCM
clinically. Schiff and O’Neill reported sensory
alteration (42.5%), pain (30%), and weakness
(30%) as the most common initial symptoms2.
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The symptoms of gait unsteadiness, urinary
incontinence, and Brown-Sequard syndrome
have also been described2,6.
Diagnosis of ISCM usually requires magnetic
resonance imaging (MRI) or computerized
tomography (CT), because plane films and
myelography are normal in 75% and 58% of
cases7. In addition, cerebral spinal fluid (CSF)
analysis is often non-diagnostic with the
most common abnormal finding of elevated
protein in only 20% of cases8. Computerize
tomography scanning has been found to be
diagnostic in few patients, which is demonstrated by increased density in the area of the
ISCM lesions. However, magnetic resonance
imaging (MRI) has greater sensitivity and
specificity7. MRI T2-weighted images show
alterations in signal intensity based on tissue
type and demonstrate accurate differentiation
between normal tissue of the spinal cord and
tumor  7. Gadolinium is a helpful adjunct to the
T2-weighted imaging as it reveals the enhancing
central lesion in typical ISCM7. In a study of 30
patients, there was only one false-negative MRI
study, and 23 of 25 patients receiving gadolinium
demonstrated contrast enhancement of ISCM
lesions on MRI2.
Treatment is generally palliative, as the median
survival ranges from 3.9 to 5 months2,9,10. Schiff
and O’Neill found that patients with breast
cancer as their primary tumor had the greatest
median survival, which still was only 13 months.
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Patients with other primary cancers including
lung carcinoma had a median survival of 3
months. As with our patient, surgery is often
contraindicated at the time of presentation,
making the less invasive modalities of chemotherapy and radiation therapy the mainstays
of treatment2,5,11. Radiation therapy has been
shown to improve or prevent deterioration
of neurological status. In Conill et al., they
reported improvement of neurological symptoms in 83% of patients with a mean duration
of 17.2 days. And Schiff and O’Neill reported
preservation of ambulation in 91% of patients
at their latest follow-up.
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